Table 1 Demographic and clinical characteristics of the patients
Variable | Â |
|---|---|
Patients treated with BPT (n) | 2371 |
Sex (% female) | 33.9 |
Age (years) | 68.8 ± 15.2 |
Sepsis (%) | 40.8 |
APACHE II score | 23.5 ± 9.4 |
SOFA score | 10.0 ± 4.4 |
Mortality | 38.3% |
Total number of BPT procedures performed (n) | 2867 |
Details of BPT [n (%)] | |
 Continuous renal replacement therapy | 1932 (67.4) |
  Continuous hemodiafiltration | 1376 (48.0) |
  Continuous hemodialysis | 382 (13.3) |
  Continuous hemofiltration | 174 (6.1) |
 Sustained low-efficiency hemodialysis | 28 (1.0) |
 Intermittent renal replacement therapy | 547 (19.1) |
 Direct hemoperfusion with PMX | 209 (7.3) |
 Direct hemoperfusion with activated carbon | 4 (0.1) |
 Simple plasma exchange | 126 (4.4) |
 Double filtration plasmapheresis | 6 (0.2) |
 Plasma adsorption | 12 (0.4) |
 Others | 3 (0.1) |
Number of modes of BPT per patient [n (%)] | |
 1 | 2041 (86.1) |
 2 | 263 (11.1) |
 3 | 54 (2.3) |
 ≥ 4 | 13 (0.5) |
Anticoagulants [n (%)] | |
 Nafamostat mesilate | 1864 (78.6) |
 Heparin | 370 (15.6) |
 Low molecular weight heparin | 14 (0.6) |
 None | 116 (4.9) |
 Others | 7 (0.3) |